Company Overview and News

 
Stocks in news: ITC, Bharti, Axis, Shemaroo, IDFC Bank, MCX, SBM

2016-10-26 moneycontrol
ITC | HUL | HDFC | Hero Motocorp | Bharti Airtel | Axis Bank | Ashok Leyland | Asian Paints | Shemaroo | IFB Agro | IDFC Bank | KSB Pumps | MCX | State Bank Of Mysore | Crompton Consumer | Bharat Bijlee and PI Industries are stocks, which are in the news today.

 
Results to watch out for! Canara Bank, Bajaj Corp in focus

2016-07-25 indiainfoline
The results which are expected today are Canara Bank, Bajaj Corp,Tata Sponge Iron, Eveready Industries,Greenply Industries, State Bank Of Mysore, Indiabulls Housing Finance.

 
Stocks in news: Axis, Cairn, Vedanta, ILFS Engg, ONGC, Vivimed

2016-07-25 moneycontrol
Axis Bank | Cairn India | Vedanta | Canara Bank | Hinduja Ventures | IL&FS Engineering | IOC | ONGC | BPCL | Chennai Petroleum | Godawari Power | Cyient | Vivimed Labs | ITI | Gujarat Fluorochemicals | Religare Enterprises and Ponni Sugar are stocks, which are in the news today.

 
Stocks in news: LT, Bharti, Tata Steel, Claris, Dishman, Zydus

2016-07-11 moneycontrol
Larsen and Toubro | Bharti Airtel | Tata Motors | Tata Steel | Vedanta | Aurobindo Pharma | Claris Lifesciences | Zydus Pharma | Dishman Pharma | Fineotex Chemicals | Jyoti Structures | Max Ventures | United Spirits | Sagar Cements | Southern Online Bio Tech | Nila Infra and Adani Transmission are stocks, which are in the news today.

 
Results to watch out for; HDFC, Godrej Consumer Products in focus

2016-01-27 indiainfoline
The results which are expected today are Colgate-Palmolive (India),HDFC, IDFC Bank,Bharti Infratel, Bharat Electronics Ltd, Godrej Consumer Products,Power Grid Corporation Of India, Just Dial,State Bank Of Mysore, Kajaria Ceramics,Neyveli Lignite Corporation, SKS Microfinance, Graphite Indiablue Star Infotech, Beryl Drugs, Accel Frontline,Bajaj Steel Industries

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

21h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...